Potential Changes to MS Treatment Access in Australia MStranslate July 2, 2026 Treatments Members of the Australian multiple sclerosis community are likely aware of media reports that two key MS medications, Ocrevus and Kesimpta, are at risk of being withdrawn from the Australian Government’s...
MS Auckland Webinar: AHSCT as a Treatment for MS MStranslate June 18, 2026 Research, Stem Cells, Treatments The second episode of an MS Auckland webinar series that MStranslate has been participating in was on the topic of Autologous Haematopoietic Stem Cell Transplant (AHSCT) as a treatment for multiple...
Multiple Sclerosis Research In 2026 MStranslate January 5, 2026 Progressive MS, Remyelination, Treatments 2026 is upon us! As fireworks ring out around the world to usher in the new year, we like to look ahead and think about what new developments we might see in multiple sclerosis research over the coming 12...
Bile Acids: A Novel Multiple Sclerosis Therapy? MStranslate August 6, 2024 Research, Treatments Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are constantly looking at novel approaches for the treatment of...
Long-term HSCT Outcomes in Norway MStranslate July 9, 2024 Research, Stem Cells, Treatments Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a new treatment approach, haematopoietic stem cell...
‘Wearing Off’ Of MS Treatments Between Doses MStranslate July 1, 2024 Research, Treatments Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major developments in the treatment of multiple sclerosis has been the...
Retinoic Acid and Calcitriol May Promote Remyelination MStranslate June 25, 2024 Remyelination, Research, Treatments Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...
BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B cells. B cells, which are important cells in the immune system,...
Neural Stem Cell Transplantation for Progressive MS MStranslate March 28, 2023 Research, Stem Cells, Treatments 1 Comment Research Summary: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study The treatment of progressive multiple sclerosis remains an unmet need. ...
Heart Medication Shows Potential to Repair Myelin MStranslate August 16, 2022 Remyelination, Research, Treatments Research Summary: Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis The ability to repair myelin damage...
